Target intelligence / Profile preview

Muscarinic acetylcholine receptor M2 & M3 (M2 and M3)

Target
M2 and M3
Molecular classification
G protein-coupled receptor (GPCR), Receptor
01

Overview

Muscarinic acetylcholine receptor M2 and M3 are two subtypes of muscarinic receptors, members of the G protein-coupled receptor (GPCR) superfamily, activated by the neurotransmitter acetylcholine. M2 is predominantly found in cardiac tissue, where it mediates inhibitory parasympathetic regulation of heart rate and contractility via Gi protein coupling. M3 is chiefly expressed in smooth muscle and glandular tissues, where it mediates excitatory responses—including smooth muscle contraction and glandular secretion—through Gq protein coupling. Both receptors are critical to autonomic nervous system function and have long-standing roles as drug targets in cardiovascular, respiratory, and neuropsychiatric diseases. Although highly homologous, selective targeting of M2 versus M3 subtypes is a major challenge and an ongoing objective in drug development due to overlapping binding pockets and physiological functions[1][2][3][4][5][7][9].

Other names
CHRM2Muscarinic receptor M2M2 muscarinic receptorCardiac muscarinic receptorCHRM3Muscarinic receptor M3M3 muscarinic receptorGlandular muscarinic receptor
02

Mechanism of action

Orthosteric antagonists: competitively inhibit acetylcholine binding - Allosteric modulators: modulate receptor response by binding at non-orthosteric sites - Bitopic ligands: bridge both orthosteric and allosteric sites, promising for selectivity[2][3] - Agonists: mimic acetylcholine to induce receptor activation

03

Biological functions

Signal transductionAutonomic (parasympathetic) nervous system signalingCardiac regulation (M2)Smooth muscle contraction (M3)Regulation of glandular secretion (M3)Regulation of neurotransmitter release
04

Disease associations

Cardiovascular disease (arrhythmias, bradycardia, heart failure—primarily M2)Respiratory disease (asthma, chronic obstructive pulmonary disease—primarily M3)Neuropsychiatric disorders (schizophrenia, Alzheimer's, Parkinson's)Gastrointestinal disorders (motility disorders—primarily M3)Urinary disorders (overactive bladder—primarily M3)Other (potential roles in diabetes and obesity via M3)
05

Safety considerations

M2: bradycardia, arrhythmias, exacerbation of heart failure due to impact on cardiac conductionM3: dry mouth, blurred vision, constipation, urinary retention, increased risk of infection due to inhibition of glandular and smooth muscle activityCNS effects: confusion, cognitive impairment, particularly in elderly due to central antimuscarinic effects
06

Interacting drugs

atropine

13 more in the full profile.

07

Biomarkers

There are no widely accepted clinical biomarkers specific to M2/M3 patient selection; however, response to muscarinic agonists/antagonists (e.g. change in heart rate for M2, airway function for M3) may be used as pharmacodynamic endpoints.

Beyond the preview

Go deeper on Muscarinic acetylcholine receptor M2 & M3 (M2 and M3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muscarinic acetylcholine receptor M2 & M3 (M2 and M3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call